Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Gastroesophageal Cancer 2025: Lima
- Start date
- 09 Apr 2025
- End date
- 10 Apr 2025
- Location
- Lima, Peru
Learning objectives
- Understand best clinical practices in the multidisciplinary management of gastroesophageal cancer, both in the neoadjuvant and metastatic settings
- Comprehend the importance of pathology and histo-prognostic factors in the treatment of gastroesophageal cancers
- Learn how to manage patients after disease progression, addressing side effects of treatments and special situations
- Gain insights into the evolving field of biomarker-targeted therapy and immunotherapy for gastroesophageal cancer
Travel grant
In addition to the course registration and the hotel accommodation, a travel grant of maximum 800 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that immigration visa costs are NOT covered by the travel grant and are the participant's responsibility.
Accreditation
The programme of this event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
